Gujarat Kidney and Super Speciality Limited IPO Details

Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India.

The company operates six multispeciality hospitals and three pharmacies as of March 20, 2025, with a total bed capacity of 400 beds, an approved capacity of 355 beds, and an operational capacity of 250 beds.

The company's hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).

Services:

• Secondary Care Services: General and surgical treatments.
  
  
• Tertiary Care Services: Super speciality surgical procedures.
  
  

Specialties:
Gujarat Superspeciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology.

Workforce:
As of March 20, 2025, the company had 322 employees, including 21 full-time consultants and 32 visiting consultants. As of September 30, 2024, the company’s healthcare professionals included 47 doctors and 138 nurses.